Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

721 recalls, newest first

Class II · Moderate risk

Pepcid Complete - 25ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0276-2026
Class II · Moderate risk

Pepto Bismol 32ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0275-2026
Class II · Moderate risk

Children Nyquil

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0274-2026
Class II · Moderate risk

Nyquil Cold & Flu -32ct/2pk

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0273-2026
Class II · Moderate risk

LIQUID NYQUIL a) regular

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0272-2026
Class II · Moderate risk

Motrin 2's Disp.- 50ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0271-2026
Class II · Moderate risk

Excedrin Migraine 2's- 25 Ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0270-2026
Class II · Moderate risk

Excedrin 2's Disp.- 30 Ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0269-2026
Class II · Moderate risk

LIQUID DAYQUIL 12/8oz

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0268-2026
Class II · Moderate risk

Dayquil Cold & Flu

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0267-2026
Class II · Moderate risk

Claritin

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0266-2026
Class II · Moderate risk

Bayer 2Pk- 25 CT

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0265-2026
Class II · Moderate risk

Benadryl

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0264-2026
Class II · Moderate risk

Alka Seltzer

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0263-2026
Class II · Moderate risk

Aleve 1's

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0262-2026
Class II · Moderate risk

Advil a) Ibuprofen

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0261-2026
Class III · Low risk

traZODONE Hydrochloride Tablets

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc NDC 68382-806-10 D-0247-2026

Recalls by year